Nattokinase Powder 5000 FU UV

¿Qué es polvo de nattoquinasa 5000FU?

La natoquinasa es una serina proteasa alcalproducida durante el metabolismo de Bacillus subtilis, una estructura polipeptídica de cadena simple sin enlaces disulfur, soluble en agua, y amarillo blanco en el estado sólido. La secuencia del ácido desoxirribonucleico (ADN) de la natoquinasa consiste de 275 residuos de aminoácidos, y su masa molecular relativa es generalmente 28000u.

El polvo de natoquinasa es una enzima natural, también conocida como enzima fibrinolíbacillus subtilis, enzima fibrinolíqk natoquinasa tiene propiedades similares a la enzima fibrinolíque descomponen la fibrina. Nattoquinasa también estimula el cuerpo's producción natural de enzimas fibrinolíticas para ayudar a apoyar la circulación normal de la sangre, flujo, y viscode la sangre. La natoquinasa es particularmente sensible a la fibrina reticul(fibrina que ha formado un coágulo de sangre) y puede degradarla directamente, sin efecto sobre la fibrina plasmática y sin riesgo de sangrado. La natoquinasa tiene un diverso mecanismo trombolítico. Además del efecto trombolítico directo descrito anteriormente, hay un pequeño efecto trombolítico indirecto.

La tecnología de primavera verde suministra nattoquinasa en polvo 5000 FU UV sin vitamina K2 y sin olor especial de amoníaco. Utilizamos alta calidad pura cepa de fermentación natoquinasa, ciclo de producción corto, alto rendimiento, bajo precio y fácil de extraer y puri. Con un equipo de investigación científica avanzada, un equipo de gestión de producción con experiencia y un equipo de ventas profesional, Green Spring puede personalizar varias proporciones de extractos, así como extractos estándar, según sea necesario. Hemos aprobado Halal, Kosher, COSMOS, BRC, IFS, FDA, ISO y otras certificaciones. Podemos proporcionar informes de prueba autorizados de terceros.

Especificaciones: 

Normativa:

Se ajusta a la normativa de la UE.

Benefits:

Reduces Blood Clot Formation

Clotting is formed through a series of chemical reactions between special blood cells (platelets) and proteins (clotting factors) in the blood and is an important defense mechanism for the body. Sometimes this process is abnormal and an abnormal clot (also known as a thrombus) develops in an artery or vein, blocking the flow of blood to surrounding tissues. Among these, acute arterial thrombosis is the proximal cause of most myocardial infarctions (heart attacks) and about 80% of strokes. In an open-label clinical trial (45 adults) with 3 groups, healthy, cardiovascular, and dialysis, all subjects were given 2 nattokinase capsules (nattokinase, a single dose of 2,000 FU) orally daily for 2 months.

The results found that coagulation factors associated with cardiovascular disease, such as fibrinogen, coagulation factor VII, and coagulation factor VIII, decreased consistently and at similar rates in all groups. Another double-blind, placebo-controlled trial (in 12 healthy young men) noted that D-dimer concentrations and blood fibrin/fibrinogen degradation products were elevated in subjects taking oral nattokinase and that the duration of action was longer (~8 hours or more).

Conclusion: Oral nattokinase may have a positive effect on inhibiting thrombosis, but more large trials are needed to confirm its clinical benefit, limited by the small sample size.

Prevention of Atherosclerosis

Atherosclerosis is a chronic disease in which arteries harden through plaque formation. Major risk factors include dyslipidaemia, diabetes, smoking, hypertension and genetic abnormalities. A randomised controlled trial (26 weeks in 82 patients with hyperlipidaemia) was conducted with two groups, one given a lipid-lowering drug: simvastatin, and the other given nattokinase (6000 FU daily dose).

After the test, it was found that the common carotid artery intima-media thickness (CCA-IMT) and carotid plaque size decreased in both groups, but the magnitude was more significant in the nattokinase group. In addition, lipid indices such as TG, TC and LDL-C decreased in both groups, but the magnitude was more significant in the simvastatin group, while nattokinase powder was able to increase HDL-C.

Conclusion: Oral nattokinase may be useful in the prevention of atherosclerosis, but due to the small sample size, more large-scale trials are needed to confirm the clinical benefits.

Liver Protection

After Nattokinase powder enters the human body, it builds an alcohol protection barrier through a triple channel: it enters the human liver system to break down the pressure on the liver to resolve alcohol and assist in alcohol detoxification; it enters the human vascular system to form a key protection barrier in the cerebrovascular region to resist the inhibitory effect of alcohol on the brain; and it enters the human digestive tract system to form a protective barrier rapidly to accelerate the acidic secretion of the digestive tract and promote alcohol detoxification.

Taking Natto can quickly solve the adverse effects of alcohol and prevent next-day drunkenness. In addition, a variety of active substances in natto activate liver cells, promote liver cell regeneration, improve liver function, protect the liver, and effectively prevent and improve fatty liver.

Applications:

For Health Products:

Nattokinase powder is widely used as a food supplement for blood thinning, prevention of thrombosis, and improvement of blood circulation in Japan, China, Korea, EU countries, Canada, and the United States. Nattokinase also has a variety of pharmacological effects such as improving microcirculation, lowering blood pressure, anticoagulation, preventing atherosclerosis, easing retinal angiogenesis, anticancer, and inhibiting inflammation and oxidative stress. It has been used as a nutraceutical additive.